Safety of celecoxib versus traditional nonsteroidal anti-inflammatory drugs in older patients with arthritis

BACKGROUND: A 2011 systematic review found an increased cardiovascular (CV) risk at both ≤200 mg/day and >200 mg/day doses of celecoxib. This study aimed to evaluate adverse drug events with celecoxib relative to traditional nonsteroidal anti-inflammatory drugs (NSAIDs) in real-world practice set...

Descripción completa

Detalles Bibliográficos
Autor principal: Shin, Sooyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299466/
https://www.ncbi.nlm.nih.gov/pubmed/30588073
http://dx.doi.org/10.2147/JPR.S186000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299466/
https://www.ncbi.nlm.nih.gov/pubmed/30588073
http://dx.doi.org/10.2147/JPR.S186000

Ejemplares similares